Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05524402 · ClinicalTrials.gov registry record · NA

Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI

A NA study of Anxiety and mTBI - Mild Traumatic Brain Injury, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05524402 is a NA study of Anxiety and mTBI - Mild Traumatic Brain Injury that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05524402, a NA study of Anxiety and mTBI - Mild Traumatic Brain Injury, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigator aims to conduct a pilot randomized controlled trial to test the feasibility of two symptom management programs for college-age individuals with recent concussions and anxiety, TOR-C 1 and TOR-C 2. The investigator will assess the feasibility of recruitment procedures (screening, eligibility, and enrollment) and data collection as well as the feasibility, credibility, and acceptability of the programs (adherence, retention, fidelity, and satisfaction), following prespecified benchmarks. Both programs will be delivered virtually (Zoom).

Interventions

  • BEHAVIORAL TOR-C 1
  • BEHAVIORAL TOR-C 2

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-10-15
Est. Completion 2024-07-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05524402

The ClinicalTrials.gov registry entry for NCT05524402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which TOR-C 1 is the first listed.

NCT05524402 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05524402 about?

NCT05524402 is a clinical study titled "Live Video Mind-body Treatment to Prevent Persistent Symptoms Following mTBI". The investigator aims to conduct a pilot randomized controlled trial to test the feasibility of two symptom management programs for college-age individuals with recent concussions and anxiety, TOR-C 1 and TOR-C 2. The investigator will assess the feasibility of recruitment procedures (screening, eli...

What is the current status of trial NCT05524402?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-15. Estimated completion is 2024-07-12.

What conditions does trial NCT05524402 study?

This clinical trial studies the following conditions: Anxiety, mTBI - Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT05524402?

The interventions under investigation include: TOR-C 1 (BEHAVIORAL), TOR-C 2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT05524402?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05524402 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.